Literature DB >> 3885471

Development of a radioimmunoassay for the measurement of prostacyclin metabolites in unextracted plasma.

M McLaren, J J Belch, C D Forbes, C R Prentice.   

Abstract

Levels of plasma 6-keto-prostaglandin F1 alpha (6-keto-PGF 1 alpha) measured in normal subjects by radioimmunoassay show wide variation. In an attempt to develop a sensitive, specific and reproducible assay for the measurement of the circulating metabolites of prostacyclin (PGI2) we examined the different variables involved in radioimmunoassay such as choice of buffer; incubation time and temperature; amount of radioisotope tracer added and the separation method. The method described gives good reproducibility and shows good correlation with in vivo and in vitro doses of PGI2.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3885471     DOI: 10.1016/0049-3848(85)90044-1

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  2 in total

1.  A double blind randomised placebo controlled trial of hexopal in primary Raynaud's disease.

Authors:  G T Sunderland; J J Belch; R D Sturrock; C D Forbes; A J McKay
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

2.  Abnormalities of vascular prostaglandins in Henoch-Schönlein purpura.

Authors:  S Turi; J J Belch; T J Beattie; C D Forbes
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.